RNS Number:6938H
Goldman Sachs International
19 February 2003

EMM DISCLOSURE

                                                             FORM 38.5 (SUMMARY)



Lodge with a RIS and the Takeover Panel.  Use a separate form for each class of
securities in which dealings have been made.





CONNECTED EXEMPT MARKET- MAKERS:
DISCLOSURE UNDER RULE 38.5 OF THE CITY CODE ON TAKEOVERS AND MERGERS





Name of EMM

Goldman Sachs International




Date of disclosure

19 February 2003



Contact name

Stuart Mclerie




Telephone number

+44 207-774-8136



Please see attached disclosure of dealings under Rule 38.5 in the securities of
the following companies:



Oxford Glycosciences plc

Cambridge Antibody Technology plc





AMENDMENT

If the attached Rule 38.5 disclosure is to amend a previous disclosure, please
state which element(s) of previous disclosure was incorrect:




In the case of option business or dealings in derivatives full details should be
given on a separate sheet so that the nature of the dealings can be fully
understood. For options this should include the number of securities under
option, the exercise period (or in the case of exercise, the exercise date), the
exercise price and any option money paid or received. For derivatives this
should include, at least, the number of reference securities to which they
relate (when relevant), the maturity date (or if applicable the closing out
date) and the reference price.



For full details of the disclosure requirements see Rules 8 and 38 of the Code.
If in doubt contact the Monitoring Section of the Panel, Tel. No: 020 7638 0129.
Email: monitoring@disclosure.org.uk








                                                                       FORM 38.5

CONNECTED EXEMPT MARKET-MAKERS:

DISCLOSURE UNDER RULE 38.5 OF THE CITY CODE ON TAKEOVERS AND MERGERS



Dealing in (name of company)
Oxford Glycosciences plc




Class of security

Contract For Differences Expiration 22 January 2013




Date of disclosure

19 February 2003



Date of dealing

17 February 2003



Name of EMM

Goldman Sachs International




Name of offeree/offeror with whom connected

Oxford Glycosciences plc




Total number of securities purchased

70,000 (customer sold to close)



Highest price paid*

1.857771 # Sterling



Lowest price paid*

1.857771 # Sterling



Total number of securities sold





Highest price received*





Lowest price received*




*Currency must be stated


                                                                       FORM 38.5

CONNECTED EXEMPT MARKET-MAKERS:

DISCLOSURE UNDER RULE 38.5 OF THE CITY CODE ON TAKEOVERS AND MERGERS



Dealing in (name of company)
Cambridge Antibody Technology plc




Class of security

Contract For Differences Expiration 22 January 2013




Date of disclosure

19 February 2003



Date of dealing

17 February 2003



Name of EMM

Goldman Sachs International




Name of offeree/offeror with whom connected

Oxford Glycosciences plc




Total number of securities purchased





Highest price paid*





Lowest price paid*





Total number of securities sold

25,522 (customer bought to close)



Highest price received*

4.605518 # Sterling



Lowest price received*
4.605518 # Sterling



*Currency must be stated




                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

EMMNKCKKBBKDABD